Use of a Repositionable and Fully Retrievable Aortic Valve in Routine Clinical Practice
The RESPOND Study and RESPOND Extension Cohort
Nicolas M. Van Mieghem, Jochen Wöhrle, David Hildick-Smith, Sabine Bleiziffer, Daniel J. Blackman, Mohamed Abdel-Wahab, Ulrich Gerckens, Axel Linke, Hüseyin Ince, Peter Wenaweser, Dominic J. Allocco, Ian T. Meredith and Volkmar Falk
Cumulative Mortality Rate in RESPOND Main Cohort Through 1 Year
The rate of all-cause mortality through 1 year was similar in the intent-to-treat (gray dashed line) and as-treated (blue line) populations. Chart shows cumulative event rates ± 1.96 SE. ITT = intent-to-treat; RESPOND = Repositionable Lotus Valve System—Post-Market Evaluation of Real World Clinical Outcomes trial.